Alnylam Pharma (ALNY) Tops Q3 EPS by 21c
Tweet
Share
E-mail
Get Alerts ALNY Hot Sheet
Price: $286.41 --0%
EPS Growth %: +409.4%
Financial Fact:
General and administrative: 17.99M
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: +409.4%
Financial Fact:
General and administrative: 17.99M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Alnylam Pharma (NASDAQ: ALNY) reported Q3 EPS of ($1.06), $0.21 better than the analyst estimate of ($1.27). Revenue for the quarter came in at $17.1 million versus the consensus estimate of $24.65 million.
For earnings history and earnings-related data on Alnylam Pharma (ALNY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
- BofA lists top 5 themes driving next $1tn in incremental semi sales
- Morgan Stanley Starts Adani Enterprises Ltd. (ADE:IN) at Overweight
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
